CSP EXAM ACTUAL TEST PAPER WITH FULL
SOLVED QUESTIONS AND CORRECT
ANSWERS GRADED A PLUS
◉ Which medication is a Jak inhibitor?
a. Humira (adalimumab)
b. Orencia (abatacept)
c. Actemra (toclizumab)
d. Xeljanz (tofacitinib). Answer: d. Xeljanz (tofacitinib)
◉ Which medication can elevate cholesterol?
a. Actemra (toclizumab)
b. Enbrel (etanercept)
c. Simponi (golimumab)
d. Kineret (anakinra). Answer: a. Actemra (toclizumab)
◉ Which shingles vaccine is safe to administer with TNF inhibitors?
a. Adacel
b. Zostavax
c. Shingrix
d. Varivax. Answer: c. Shingrix
,◉ Most biologics increase the risk of infections, which of the
following also increases the risk of
neutropenia?
a. Rituxin (rituximab)
b. Taltz (ixekizumab)
c. Remicade (infliximab)
d. Cimzia (certolizumab pegol). Answer: b. Taltz (ixekizumab)
◉ Which psoriasis medication does not require screening for
tuberculosis?
a. Stelara (ustekinumab)
b. Otezla (apremilast)
c. Cocentyx (seculinumab)
d. Humira (adalimumab). Answer: b. Otezla (apremilast)
◉ What is the standard starting dose for Taltz (ixekizumab) when
used to treat psoriatic arthritis?
a. 160mg subcutaneously once, followed by 80mg subcutaneously at
weeks 2, 4, 6, 8, 10
and 12; then 80mg subcutaneously every 4 weeks
b. 160mg subcutaneously once, followed by 80mg subcutaneously
every 4 weeks
c. 160mg subcutaneously once, followed by 80mg subcutaneously
every week for 4 weeks,
then 80mg every 4 weeks
, d. 160mg subcutaneously once, followed by 80mg subcutaneously
every other week. Answer: b. 160mg subcutaneously once, followed
by 80mg subcutaneously every 4 weeks
◉ A 45 y/o, 200lb patient is struggling with severe dermatitis and the
provider wants to potentially
start a biologic. Which medication would you recommend?
a. Protopic (tacrolimus)
b. Humira (adalimumab)
c. Stelara (ustekinumab)
d. Dupixent (dupilumab). Answer: d. Dupixent (dupilumab)
◉ A 56 y/o, 140lb patient with psoriasis will be starting Stelara
(ustekinumab), but the provider
wants to verify the dosing of the medication. What starting dose
would you recommend?
a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg
every 12 weeks
b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90 mg
every 12 weeks
c. Infuse 260 mg IV over at least 1 hour as a single dose, followed 8
weeks later with 90 mg
subcutaneously every 8 weeks
d. Infuse 520 mg IV over at least 1 hour as a single dose, followed 8
weeks later with 90 mg
SOLVED QUESTIONS AND CORRECT
ANSWERS GRADED A PLUS
◉ Which medication is a Jak inhibitor?
a. Humira (adalimumab)
b. Orencia (abatacept)
c. Actemra (toclizumab)
d. Xeljanz (tofacitinib). Answer: d. Xeljanz (tofacitinib)
◉ Which medication can elevate cholesterol?
a. Actemra (toclizumab)
b. Enbrel (etanercept)
c. Simponi (golimumab)
d. Kineret (anakinra). Answer: a. Actemra (toclizumab)
◉ Which shingles vaccine is safe to administer with TNF inhibitors?
a. Adacel
b. Zostavax
c. Shingrix
d. Varivax. Answer: c. Shingrix
,◉ Most biologics increase the risk of infections, which of the
following also increases the risk of
neutropenia?
a. Rituxin (rituximab)
b. Taltz (ixekizumab)
c. Remicade (infliximab)
d. Cimzia (certolizumab pegol). Answer: b. Taltz (ixekizumab)
◉ Which psoriasis medication does not require screening for
tuberculosis?
a. Stelara (ustekinumab)
b. Otezla (apremilast)
c. Cocentyx (seculinumab)
d. Humira (adalimumab). Answer: b. Otezla (apremilast)
◉ What is the standard starting dose for Taltz (ixekizumab) when
used to treat psoriatic arthritis?
a. 160mg subcutaneously once, followed by 80mg subcutaneously at
weeks 2, 4, 6, 8, 10
and 12; then 80mg subcutaneously every 4 weeks
b. 160mg subcutaneously once, followed by 80mg subcutaneously
every 4 weeks
c. 160mg subcutaneously once, followed by 80mg subcutaneously
every week for 4 weeks,
then 80mg every 4 weeks
, d. 160mg subcutaneously once, followed by 80mg subcutaneously
every other week. Answer: b. 160mg subcutaneously once, followed
by 80mg subcutaneously every 4 weeks
◉ A 45 y/o, 200lb patient is struggling with severe dermatitis and the
provider wants to potentially
start a biologic. Which medication would you recommend?
a. Protopic (tacrolimus)
b. Humira (adalimumab)
c. Stelara (ustekinumab)
d. Dupixent (dupilumab). Answer: d. Dupixent (dupilumab)
◉ A 56 y/o, 140lb patient with psoriasis will be starting Stelara
(ustekinumab), but the provider
wants to verify the dosing of the medication. What starting dose
would you recommend?
a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg
every 12 weeks
b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90 mg
every 12 weeks
c. Infuse 260 mg IV over at least 1 hour as a single dose, followed 8
weeks later with 90 mg
subcutaneously every 8 weeks
d. Infuse 520 mg IV over at least 1 hour as a single dose, followed 8
weeks later with 90 mg
